Amerijet achieves IATA CEIV Pharma recertification
07 / 08 / 2020
US-based Amerijet International Airlines has achieved IATA CEIV Pharma recertification following an independent assessment carried out by the association.
The recertification marks the carrier’s capability of handling pharma and temperature-sensitive cargo at IATA’s globally recognised standard.
Located at Miami International Airport, Amerijet’s 360,000 sq ft (33,500 sq m) facility is comprised of dry warehouse space, a 40,000 sq ft (3,700 sq m) perishable handling center, offices and exclusive ramp access for aircraft handling and parking.
In addition to 49 dry cargo, 12 cold storage, and three pharma receiving doors, the warehouse offers landside and airside access to help streamline cargo flows.
Amerijet’s computer-monitored perishable handling center and temperature-controlled receiving area were designed to store refrigerated, frozen and chilled cargo to “maintain the cold chain integrity” of pharma and perishables.
Rasheme Richardson, vice president of airport operations at Amerijet, commented: “The pharmaceutical supply chain consists of a historically demand-driven as well as a growing patient-driven model, due to the rise of personalised medicines, which makes speed and traceability even more relevant. We provide our customers with quality standards through uniformed processes, transparency, and a compliant network.”
Ronald Irish, temperature control manager at Amerijet, added: “We are continuously reinforcing our internal processes through training, collaboration, and partnering with like-minded suppliers. Achieving the CEIV Pharma recertification is evidence that Amerijet continues to advance, towards the strategic objective of remaining an important stakeholder in the transportation of pharmaceuticals.”